Nagpur GMCH Reports Significant Progress in Drug-Resistant TB Treatment Since 2007
In a comprehensive report released ahead of World Tuberculosis Day on March 24, the Government Medical College and Superspeciality Hospital (GMCH) in Nagpur has revealed that more than 2,900 patients with drug-resistant tuberculosis (DR-TB) have undergone treatment at their facility since 2007. The data shows encouraging progress, with over 1,736 patients successfully treated or cured, representing a significant achievement in India's fight against this challenging disease.
Alcohol Use Emerges as Major Risk Factor in TB Cases
Professor Dr. Sushant Meshram, head of the Pulmonary Medicine Department at GMCH Nagpur, shared that a striking 60% of the treated patients had a history of alcohol use. "Alcohol abuse significantly weakens immunity, making individuals more vulnerable to contracting this airborne disease," Dr. Meshram explained. He emphasized that addressing such risk factors is critical to improving treatment outcomes and reducing transmission within communities.
Detailed Patient Outcomes and Demographics
The hospital's data reveals that 377 patients (approximately 13%) succumbed to the disease despite treatment efforts, while 265 patients defaulted on their treatment regimens. Currently, 262 patients remain under active treatment, demonstrating the center's sustained follow-up efforts.
Key demographic findings include:
- Nearly 70% of patients fall within the 15-44 age group
- Men account for about 62% of all cases
- A significant number of patients were underweight, highlighting the role of malnutrition alongside alcohol use in worsening treatment outcomes
Treatment Challenges and Successes
Dr. Meshram noted that while the treatment success rate is encouraging, persistent challenges include mortality and treatment default rates. "These challenges require stronger patient counseling and enhanced support systems to ensure better adherence to treatment protocols," he stated.
The report also highlighted a positive shift toward all-oral treatment regimens for DR-TB, which are improving patient comfort and adherence by eliminating the need for painful injectable drugs.
Concerning XDR-TB Statistics Revealed
Extensively drug-resistant TB (XDR-TB) remains a serious concern, with the center treating 47 such patients. Of these, only 11 achieved cure or treatment completion, while 27 died, reflecting a high mortality rate of approximately 57%. Six patients defaulted from treatment, and most cases occurred in the younger age group of 15-44 years.
National and Regional TB Burden
Tuberculosis, an airborne infectious disease that spreads through droplets when infected individuals cough or sneeze, primarily affects the lungs. India continues to bear a significant share of the global TB burden, accounting for nearly 25-27% of all cases worldwide.
In Maharashtra alone, approximately 2.5 to 3 lakh TB cases are reported annually, with Nagpur district contributing about 8,000 to 10,000 cases each year to this total.
Healthcare Professionals Emphasize Awareness and Early Diagnosis
Healthcare professionals and medical students have reiterated the importance of awareness campaigns, early diagnosis, and strict adherence to treatment under India's National Tuberculosis Elimination Programme (NTEP). "A significant proportion of TB patients we see have associated risk factors like alcohol use and malnutrition," Dr. Meshram emphasized. "Addressing these social determinants is absolutely critical to improving treatment outcomes and reducing disease transmission in our communities."
The comprehensive data from GMCH Nagpur provides valuable insights into the ongoing battle against drug-resistant tuberculosis in central India, highlighting both progress made and challenges that require continued attention from public health authorities.
